Disagreement Index
Transparency in AI disagreement. This index shows topics where the four consensus models (Gemini 3, Gemini 3 Pro, Sonnet 4.5, GPT 5.2) showed divergent conclusions. Where evidence diverges or uncertainty exists, Alerah explicitly surfaces disagreement rather than forcing a single authoritative answer.
| Topic | Score | Disagreement Summary |
|---|---|---|
| Hypertension Management | 92% | Minor disagreement exists regarding initial choice between drug classes in uncomplicated hypertension. Some guidelines prefer ACE inhibitors while others consider all four classes equivalent. |
| Type 2 Diabetes Initial Management | 94% | Consensus exists on metformin as first-line. Disagreement centers on when to add second-line agents and which class to prioritize (GLP-1 RA vs SGLT2i) in patients without established cardiovascular or renal disease. |
Disclaimer: These consensus summaries are for informational purposes only and do not constitute medical advice.
Always consult qualified healthcare professionals for clinical decisions.